Skip to main content
SpringerLink
Log in

Managing dyspepsia

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

The prevalence of dyspepsia in the general population is as high as 40%, and its management represents a considerable financial burden to the health care system. Causes of dyspepsia amenable to medical therapy include peptic ulcer and functional dyspepsia, and testing for Helicobacter pylori and treating positive individuals is beneficial in both conditions. Individuals presenting for the first time with uninvestigated dyspepsia, age greater than 50 years, or alarm features require upper gastrointestinal (GI) endoscopy to exclude gastroesophageal malignancy. Upper GI endoscopy for younger individuals without alarm features is not cost-effective compared with the “test and treat” approach. Test and treat and empirical acid-suppression using a proton pump inhibitor (PPI) have similar costs and effects. Recent evidence suggests that empirical acid suppression commencing with antacids is as effective as PPI. Screening and treatment of H. pylori in PPI users and the community may reduce the costs of managing dyspepsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Ford AC, Marwaha A, Lim A, et al.: Prevalence of clinically significant endoscopic findings in individuals with and without dyspepsia: systematic review and meta-analysis [abstract]. Gastroenterology 2009, 136(Suppl 1):A488.

    Google Scholar 

  2. Colin-Jones DG, Bloom B, Bodemar G, et al.: Management of dyspepsia: report of a working party. Lancet 1988, 331:576–579.

    Article  Google Scholar 

  3. Talley NJ, Colin-Jones DG, Koch KL, et al.: Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology Intl 1991, 4:145–160.

    Google Scholar 

  4. Tack J, Talley NJ, Camilleri M, et al.: Functional gastroduodenal disorders. Gastroenterology 2006, 130:1466–1479.

    Article  PubMed  Google Scholar 

  5. Agreus L, Svardsudd K, Nyren O, et al.: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995, 109:671–680.

    Article  PubMed  CAS  Google Scholar 

  6. Moayyedi P, Forman D, Braunholtz D, et al.: The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 2000, 95:1448–1455.

    Article  PubMed  CAS  Google Scholar 

  7. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000, 95:67–71.

    Article  PubMed  CAS  Google Scholar 

  8. Ford AC, Forman D, Bailey AG, et al.: Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 2007, 56:321–327.

    Article  PubMed  Google Scholar 

  9. Minocha A, Chad W, Do W, et al.: Racial differences in epidemiology of irritable bowel syndrome alone, un-investigated dyspepsia alone, and “overlap syndrome” among African Americans compared to Caucasians: a population-based study. Dig Dis Sci 2006, 51:218–226.

    Article  PubMed  Google Scholar 

  10. Ford AC, Forman D, Bailey AG, et al.: Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther 2008, 28:1013–1020.

    Article  PubMed  CAS  Google Scholar 

  11. Ford AC, Forman D, Bailey AG, et al.: Who consults with dyspepsia? Results from a longitudinal ten-year follow-up study. Am J Gastroenterol 2007, 102:957–965.

    Article  PubMed  Google Scholar 

  12. Talley NJ, Zinsmeister AR, Schleck CD, et al.: Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992, 102:1259–1268.

    PubMed  CAS  Google Scholar 

  13. Penston JG, Pounder RE: A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996, 10:83–89.

    PubMed  CAS  Google Scholar 

  14. Levin TR, Schmittdiel JA, Kunz K, et al.: Costs of acid-related disorders to a health maintenance organization. Am J Med 1997, 103:520–528.

    Article  PubMed  CAS  Google Scholar 

  15. Moayyedi P, Mason J: Clinical and economic consequences of dyspepsia in the community. Gut 2002, 50(Suppl 4):10–12.

    Google Scholar 

  16. Talley NJ, Vakil NB, Moayyedi P: American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005, 129:1756–1780.

    Article  PubMed  Google Scholar 

  17. National Institute for Clinical Excellence: Dyspepsia: managing dyspepsia in adults in primary care. Available at http://www.nice.org.uk/nicemedia/pdf/CG017fullguideline.pdf 2004. Accessed April 2009.

  18. Talley NJ, Vakil N, Practice Parameters Committee of the American College of Gastroenterology: Guidelines for the management of dyspepsia. Am J Gastroenterol 2005, 100:2324–2337.

    Article  PubMed  Google Scholar 

  19. Vakil N, Moayyedi P, Fennerty MB, et al.: Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology 2006, 131:390–401.

    Article  PubMed  Google Scholar 

  20. El-Serag H, Sonnenberg A: Opposing time trends of peptic ulcer and reflux disease. Gut 1998, 43:327–333.

    PubMed  CAS  Google Scholar 

  21. Nomura A, Stemmerman GN, Chyou P-H, et al.: Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994, 120:977–981.

    PubMed  CAS  Google Scholar 

  22. Sonnenberg A, Schwartz JS, Cutler AF, et al.: Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Arch Intern Med 1998, 158:852–860.

    Article  PubMed  CAS  Google Scholar 

  23. Ford AC, Delaney BC, Forman D, et al.: Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol 2004, 99:1833–1855.

    Article  PubMed  Google Scholar 

  24. Rauws EAJ, Langenberg W, Houthoff HJ, et al.: Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988, 94:33–40.

    PubMed  CAS  Google Scholar 

  25. Laine L, Schoenfeld P, Fennerty MB: Therapy for Helicobacter pylori in patients with non-ulcer dyspepsia: a meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 134:361–369.

    PubMed  CAS  Google Scholar 

  26. Moayyedi P, Soo S, Deeks JJ, et al.: Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Br Med J 2000, 321:659–664.

    Article  CAS  Google Scholar 

  27. Moayyedi P, Deeks J, Talley NJ, et al.: An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in non-ulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003, 98:2621–2626.

    Article  PubMed  Google Scholar 

  28. Moayyedi P, Soo S, Deeks J, et al.: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006, (2):CD002096.

  29. Moayyedi P, Soo S, Deeks J, et al.: Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006, (4):CD001960.

  30. Abraham NS, Moayyedi P, Daniels B, et al.: The methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther 2004, 19:631–641.

    Article  PubMed  CAS  Google Scholar 

  31. Moayyedi P, Delaney BC, Vakil N, et al.: The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004, 127:1329–1337.

    Article  PubMed  Google Scholar 

  32. Ford AC, Talley NJ, Schoenfeld PS, et al.: Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009, 58:367–378.

    Article  PubMed  CAS  Google Scholar 

  33. Soo S, Moayyedi P, Deeks JJ, et al.: Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005, (2):CD002301.

  34. Arents NLA, Thijs JC, van Zwet AA, et al.: Approach to treatment of dyspepsia in primary care: a randomized trial comparing ‘test and treat’ with prompt endoscopy. Arch Intern Med 2003, 163:1606–1612.

    Article  PubMed  Google Scholar 

  35. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB: Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994, 343:811–816.

    Article  PubMed  CAS  Google Scholar 

  36. Delaney BC, Wilson S, Roalfe A, et al.: Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet 2000, 356:1965–1969.

    Article  PubMed  CAS  Google Scholar 

  37. Delaney BC, Wilson S, Roalfe A, et al.: Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. Br Med J 2001, 322:898–901.

    Article  CAS  Google Scholar 

  38. Duggan AE, Elliott CA, Miller P, et al.: Clinical trial: a randomized trial of endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care. Aliment Pharmacol Ther 2009, 29:55–68.

    Article  CAS  Google Scholar 

  39. Jarbol DE, Kragstrup J, Stovring H, et al.: Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial. Am J Gastroenterol 2006, 101:1200–1208.

    Article  PubMed  Google Scholar 

  40. Lassen AT, Pedersen FM, Bytzer P, et al.: Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000, 356:455–460.

    Article  PubMed  CAS  Google Scholar 

  41. Lewin van den Broek NT, Numans ME, Buskens E, et al.: A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome. Br J Gen Pract 2001, 51:619–624.

    PubMed  CAS  Google Scholar 

  42. McColl KEL, Murray LS, Gillen D, et al.: Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. Br Med J 2002, 324:999–1002.

    Article  CAS  Google Scholar 

  43. Ford AC, Qume M, Moayyedi P, et al.: Helicobacter pylori “test and treat” or endoscopy for managing dyspepsia? An individual patient data meta-analysis. Gastroenterology 2005, 128:1838–1844.

    Article  PubMed  Google Scholar 

  44. Ford AC, Moayyedi P, Jarbol DE, et al.: Meta-analysis: Helicobacter pylori “test and treat” compared with empirical acid suppression for managing dyspepsia. Aliment Pharmacol Ther 2008, 28:534–544.

    Article  PubMed  CAS  Google Scholar 

  45. Lassen AT, Hallas J, Schaffalitzky de Muckadell OB: Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow-up of a randomised controlled trial. Gut 2004, 53:1758–1763.

    Article  PubMed  CAS  Google Scholar 

  46. Delaney BC, Qume M, Moayyedi P, et al.: Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multi-centre randomised controlled trial (MRC-CUBE trial). Br Med J 2008, 336:651–654.

    Article  CAS  Google Scholar 

  47. van Marrewijk CJ, Mujakovic S, Fransen GAJ, et al.: Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 2009, 373:215–225.

    Article  PubMed  CAS  Google Scholar 

  48. Raghunath AS, Hungin AP, Mason J, et al.: Helicobacter pylori eradication in long-term proton pump inhibitor users in primary care: a randomized controlled trial. Aliment Pharmacol Ther 2007, 25:585–592.

    Article  PubMed  CAS  Google Scholar 

  49. Helicobacter and Cancer Collaborative Group: Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001, 49:347–353.

    Article  Google Scholar 

  50. Lane JA, Murray LJ, Noble S, et al.: Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol Helicobacter project: randomised controlled trial. Br Med J 2006, 332:199–202.

    Article  Google Scholar 

  51. Moayyedi P, Feltbower R, Brown J, et al.: Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000, 355:1665–1669.

    Article  PubMed  CAS  Google Scholar 

  52. Mason J, Axon ATR, Forman D, et al.: The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomised controlled trial. Aliment Pharmacol Ther 2002, 16:559–568.

    Article  PubMed  CAS  Google Scholar 

  53. Ford AC, Forman D, Bailey AG, et al.: A community screening program for Helicobacter pylori saves money: ten-year follow-up of a randomised controlled trial. Gastroenterology 2005, 129:1910–1917.

    Article  PubMed  Google Scholar 

  54. Talley NJ, Fock KM, Moayyedi P: Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008, 103:510–514.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Academic Medicine, St. James’s University Hospital, Leeds, LS9 7TF, UK

    Alexander C. Ford

Authors
  1. Alexander C. Ford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Moayyedi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander C. Ford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ford, A.C., Moayyedi, P. Managing dyspepsia. Curr Gastroenterol Rep 11, 288–294 (2009). https://doi.org/10.1007/s11894-009-0042-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-009-0042-2

Keywords

Search

Navigation